NumFin

China Reform Health Management and Services Group Co., Ltd.

Sümbol: 000503.SZ

SHZ

9.53

CNY

Turuhind täna

  • -115.5998

    P/E suhe

  • -2.4733

    PEG suhe

  • 9.74B

    MRK Cap

  • 0.00%

    DIV tootlus

China Reform Health Management and Services Group Co., Ltd. (000503-SZ) Finantsaruanded

Download
AastaneQuarterly
LineaarneLog
Diagrammil näete China Reform Health Management and Services Group Co., Ltd. (000503.SZ) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist 219.991 M, mis on 0.094 % gowth. Kogu perioodi keskmine brutokasum on 79.994 M, mis on -0.159 %. Keskmine brutokasumi suhtarv on 0.320 %. Ettevõtte eelmise aasta tulemuse puhaskasv on -0.055 %, mis on võrdne -0.808 % % keskmiselt kogu ettevõtte ajaloo jooksul.,

AastaneQuarterly
10Y20Y30Y40Y

Bilanss

Sukeldudes China Reform Health Management and Services Group Co., Ltd. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja 0. Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus 0.767. Käibevara valdkonnas on 000503.SZ aruandlusvaluutas 1590.197. Märkimisväärne osa neist varadest, täpsemalt 1379.156, hoitakse sularahas ja lühiajalistes investeeringutes. See segment näitab eelmise aasta andmetega võrreldes muutust 1.340%. Ettevõtte võlaprofiil näitab, et ettevõtte pikaajaline koguvõlg on 0.674 aruandlusvaluutas. See näitaja tähendab, et aastane muutus on 2.518%. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud 1420.251 aruandlusvaluutas. Selle aspekti aastane muutus on 0.997%. Kui süveneda ettevõtte finantsnäitajatesse, ilmneb täiendavaid üksikasju. Netovõlad on hinnatud 206.577, varude hind on 2.04 ja firmaväärtus 0, kui see on olemas. Kogu immateriaalne vara, kui see on olemas, hinnatakse 175.06.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995199419931992

balance-sheet.row.cash-and-short-term-investments

3704.561379.2589.4756.7
938.8
809.7
739.5
706.7
1038.2
939.5
836.5
647.3
493.6
385.2
463.8
264
183.4
163.5
221.5
418.4
393.6
565.8
68.8
88.2
88.3
10.1
16.6
3.7
11.3
15.8
22.1
59.2
11.3

balance-sheet.row.short-term-investments

1742.09451.1419.9403.8
442.1
97.7
68
72.2
116.1
128.2
124.1
113.1
95.3
153.3
237
69.5
0.1
0
449.4
62.9
0.3
1
0.5
0
0
2.1
0
0
1.4
6.6
7.5
21.1
0

balance-sheet.row.net-receivables

810.26206.6183.5111.1
76.4
74.5
25.1
243.3
74.2
240.7
315.9
412.4
946.9
866.4
1048.3
920.2
1348.8
1064.9
990.1
457
407.4
428.5
427.4
310.7
98.7
80.4
10.5
4.2
34.3
67.4
29.1
23.7
20

balance-sheet.row.inventory

-833.92-419.90
0
0
0.1
0.1
0.1
0.5
0.5
0.8
0.7
0.6
0.7
0.2
0.3
1.3
1.4
36.1
57.5
50.4
44.3
63
34.7
22.3
17.9
16.5
36.1
22.1
15.4
18.6
16.1

balance-sheet.row.other-current-assets

13.142.43.89.5
15.2
22.8
4.1
3
1.8
1.4
2.6
67.4
-376.4
-191.9
-276
0.1
-394.4
-232.4
-280.6
116.2
-116.8
-141.6
-119.7
-83.7
82.3
134.5
121.2
68.7
192.2
93
100.5
65.8
-0.2

balance-sheet.row.total-current-assets

4539.261590.2776.3877.2
1030.4
907
768.7
953.2
1114.3
1182.1
1155.5
1127.8
1064.8
1060.2
1236.8
1184.4
1138.2
997.2
932.3
1027.6
741.7
903
420.8
378.2
304
247.3
166.2
93
274
198.3
167.1
167.2
47.2

balance-sheet.row.property-plant-equipment-net

55.613.418.822.6
11.7
12.4
33.1
39.2
47
70.6
106
92.4
85.2
82.6
88.7
96
93.5
123.4
129.5
260.1
270.3
216.8
236
240.4
423.4
353.9
421.6
383.4
417.4
114.7
329.1
129.8
94.2

balance-sheet.row.goodwill

0000
0
0
0
0
0
0.2
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

687.88175.1152.7144.1
147.2
198.1
207
218.9
209.5
138.4
89.9
73.3
63.1
51.4
130
174.7
208.2
222.6
255
305.3
335.3
270.7
81
26.9
33.5
30.6
31.2
18
18.2
7.3
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

687.88175.1152.7144.1
147.2
198.1
207
218.9
209.5
138.6
90.3
73.7
63.5
51.8
130.4
175.1
208.6
223
255
305.3
335.3
270.7
81
26.9
33.5
30.6
31.2
18
18.2
7.3
0
0
0

balance-sheet.row.long-term-investments

-1085.79-281.4-265.9-258.7
-340.1
83.4
167.3
162.1
-4.5
-47.3
-50.6
5.9
80.1
50.2
-159
76.4
167
0
0.4
157.1
338.9
140.9
282
0
0
122.6
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

4.391.60.60.4
0.2
0.1
0.1
0
1.1
1.1
1.1
1.1
1.1
2
0.2
0.2
0.2
0.1
1.2
0
12.9
0
0
0
0
9.6
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

1749.96452.8422.2406.7
447.5
104.2
104.2
75.2
124.8
136.6
132.6
127.1
183.7
172.8
257.6
91.8
24.7
297
451
69.6
119.2
8.4
6.2
291.4
206.2
0.3
111.8
120.5
81.3
267.8
173.7
155.7
0.8

balance-sheet.row.total-non-current-assets

1412.04361.3328.4315.1
266.4
398.2
511.6
495.4
378
299.7
279.4
300.2
413.7
359.4
318
439.5
494
643.4
837.2
792.2
1076.5
636.9
605.3
558.6
663.1
517
564.6
522
516.8
389.9
502.8
285.4
95

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

5951.31951.51104.71192.3
1296.8
1305.2
1280.4
1448.6
1492.3
1481.8
1434.9
1428
1478.5
1419.7
1554.8
1623.9
1632.2
1640.6
1769.5
1819.8
1818.2
1539.9
1026
936.8
967.1
764.3
730.8
615
790.8
588.1
669.8
452.7
142.3

balance-sheet.row.account-payables

55.125.78.34.3
2.3
2.6
1.2
2
1.6
0.8
0.9
1.6
1.3
1.4
1.2
1.4
1.6
0.7
88.7
15.9
5.2
5.1
10.8
6.5
19.9
12.2
11.1
12.5
49.6
54.9
6.9
0.5
0.2

balance-sheet.row.short-term-debt

719.76193.351.647.7
50.1
-17.7
0
0
0
0
22.5
60
60
10.2
89.3
149
152
105.4
96
115
60
105
172.6
176.6
153.8
118.2
118
112.7
111
117.4
77
57
25

balance-sheet.row.tax-payables

53.3915.514.311.9
10.4
7.7
8.3
8.6
16.1
32.5
17.6
15.9
13.5
4.3
4.1
8
12.9
7.6
5.1
2.8
8
12.8
22.1
25
14.6
3.4
-1.3
-6
-8.7
-4.3
2.4
0.6
0.7

balance-sheet.row.long-term-debt-total

5.860.73.52.1
10.8
0
0
0.1
0.8
1.6
2.2
2.9
3.5
4
4.5
5
0
0
0
137.2
217.4
260.4
190.4
190.4
190.4
144.1
143.8
148.8
2.2
1.7
164.3
18
11.3

Deferred Revenue Non Current

-1.54-0.800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

1.54---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

0.010281.90
0
75.2
61.5
53.6
76.7
99.5
5
7.1
16.7
2.5
4.9
5.4
6.7
10.1
4.1
10.6
5.1
7.6
8.2
14.4
7.8
6.7
17.8
0.9
10.3
9.6
0.3
38.4
0

balance-sheet.row.total-non-current-liabilities

7.41.43.52.1
10.8
0
0
0.1
0.8
1.6
2.2
2.9
3.5
4
4.5
5
0
0
7.3
137.2
217.4
260.4
190.4
190.4
193.4
141.1
141.1
145.5
157.3
6.8
164.3
18
11.3

balance-sheet.row.other-liabilities

0000
-10.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

5.860.73.52.1
10.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

1911.18530.2391.7405.1
332.6
77.7
62.7
55.6
79.1
101.9
106.7
155.7
189.6
158.8
259.5
313.1
313.6
274.9
357.9
385.9
372.3
448.7
457.8
472.9
460.5
382.2
422.3
357
372
210.9
294.6
113.8
39.8

balance-sheet.row.preferred-stock

391.7104.4142.4156.7
116.8
98.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

3778.53984.2906.4907.2
898.8
898.8
898.8
898.8
898.8
898.8
898.8
898.8
898.8
898.8
749
749
749
749
749
749
749
374.5
342.3
342.3
342.3
201.3
201.3
201.3
201.3
201.3
195
150
100

balance-sheet.row.retained-earnings

-726.91-163-83.51
179.1
422.7
409.3
615
598.3
570.3
547.2
522.2
509.2
485.1
467.1
453.9
446
440.6
408.3
381.6
344.2
189.7
112.5
32.7
39
-24.3
-101.3
-131
31.8
0
0
0
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

-391.7-104.4-142.4-156.7
-116.8
-98.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

983.1599.1-111.6-122.6
-116.8
-98.3
-94.9
-108.7
-75.1
-92.6
-135.7
-164.7
-133.2
-151.1
64
82.9
96.3
147.8
230.7
290.1
315.4
476.2
77.4
63.2
66.2
200.1
203.6
183.4
180.9
171.1
180.2
188.9
2.4

balance-sheet.row.total-stockholders-equity

4034.721420.3711.4785.6
961.1
1223.2
1213.2
1405.1
1422
1376.4
1310.3
1256.3
1274.8
1232.9
1280.2
1285.8
1291.3
1337.4
1388.1
1420.7
1408.5
1040.4
532.1
438.2
447.5
377.1
303.7
253.7
414
372.5
375.2
338.9
102.4

balance-sheet.row.total-liabilities-and-stockholders-equity

5951.31951.51104.71192.3
1296.8
1305.2
1280.4
1448.6
1492.3
1481.8
1434.9
1428
1478.5
1419.7
1554.8
1623.9
1632.2
1640.6
1769.5
1819.8
1818.2
1539.9
1026
936.8
967.1
764.3
730.8
615
790.8
588.1
669.8
452.7
142.3

balance-sheet.row.minority-interest

5.411.11.61.6
3.1
4.3
4.4
-12.1
-8.8
3.5
17.9
16
14.1
27.9
15.1
25.1
27.3
28.3
23.5
13.2
37.4
50.8
36.1
25.7
59.1
4.9
4.8
4.4
4.7
4.7
0
0
0

balance-sheet.row.total-equity

4040.121421.3713787.2
964.2
1227.5
1217.6
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

5951.3---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

656.3169.7154.1145.1
102
181.1
235.3
234.3
111.6
81
73.5
119
175.4
203.5
78.1
145.8
167.1
293
449.8
220
339.2
141.9
282.5
282.2
193.5
124.7
102.2
0
1.4
6.6
7.5
21.1
0

balance-sheet.row.total-debt

725.62193.955.149.7
50.1
0
0
0.1
0.8
1.6
24.7
62.9
63.5
14.2
93.8
154
152
105.4
96
252.2
277.4
365.4
362.9
366.9
344.2
118.2
118
112.7
113.2
119.1
77
57
36.3

balance-sheet.row.net-debt

-1236.85-734.1-114.3-303.1
-446.6
-712.1
-671.5
-634.5
-921.2
-809.7
-687.7
-471.3
-334.9
-217.7
-133
-40.5
-31.3
-58.2
-125.5
-103.3
-115.9
-199.5
294.6
278.7
255.9
110.1
101.5
109
103.3
110
62.4
18.9
25

Rahavoogude aruanne

China Reform Health Management and Services Group Co., Ltd. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab 0.220 nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides -5.96, mis tähistab 8.579 erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli -20847475.570. See on -0.596 nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte 39.6, 0, -45, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid 0.000, kusjuures erinevus võrreldes eelmise aastaga oli 0.000. Lisaks eraldas ettevõte -1.35 aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui 35.06, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998

cash-flows.row.net-income

-76.31-84.5-177.1-243.3
15.5
-188.7
-0.3
13.1
9.6
19.3
12.3
22.4
19
10.8
6.3
5.7
2.7
21.2
34.5
351.9
98.8
103.2
100.1
80.4
82.3
22.3

cash-flows.row.depreciation-and-amortization

38.3339.636.332.3
32.4
32.7
34.2
28.3
23.1
20.2
28.3
27.2
36.1
44.6
47.6
47
39.6
52.8
64.2
63.5
28.7
20
25.5
36
33.2
30.8

cash-flows.row.deferred-income-tax

-12.69-0.2-0.2-0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

1.632.41.60.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

-15.47-95.7-15-16.7
39.4
127.6
-102.8
103
87.4
-67.9
137.4
28.4
66.4
-37.5
-16.4
-97.5
-77.5
-45.1
-9.8
-40
80.6
-80.3
-73.8
91.5
-131.5
-48.1

cash-flows.row.account-receivables

-12.31-80.6-45-54.4
25.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-2.04000
0
0.1
0
0.3
0.1
0.2
-0.1
-0.1
0.1
-0.5
0.2
1.1
0.1
0.5
21.5
-7.2
-6.2
18.8
-37.1
-12.2
-4.7
11.3

cash-flows.row.account-payables

0-14.930.237.7
14.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

-1.12-0.2-0.2-0.1
0
127.5
-102.8
102.7
87.3
-68.2
137.5
28.6
66.3
-37
-16.6
-98.6
-77.6
-45.6
-31.3
-32.8
86.9
-99.1
-36.7
103.7
-126.8
-59.4

cash-flows.row.other-non-cash-items

-53.02-21.849.7134.8
-21.3
5.2
-172.7
-121.5
-106.7
3.6
-18.4
-12.2
-49.1
-28.4
4.1
29.4
6.7
-63.8
-108.2
-322
9.7
7.1
-50.8
14.7
-13.1
-23.3

cash-flows.row.net-cash-provided-by-operating-activities

-119.16000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-55.05-37.7-23.1-17.7
-32.5
-37.5
-93.2
-109.7
-76.5
-44.3
-42.1
-39.4
-6.2
-5.3
-13.2
-27.4
-75.4
-24.1
-29.1
-249.7
-240.4
-37.4
-77
-77.6
-4.1
-0.7

cash-flows.row.acquisitions-net

0.120.30.60
19.4
75.6
32.6
142.9
183.7
0.4
42.2
40.3
0.1
40
0.5
-2.6
11.2
38.4
0.6
0
257.9
37.4
30
0
4.1
0.8

cash-flows.row.purchases-of-investments

0-6-91.6-116.3
-25
0
-7.7
-49.5
-76
-92.7
-61.6
-184
-630.4
-752.2
-776.8
-225.7
-121.2
-338
-128.6
-202.5
-58.8
-41.9
-88.4
-166.1
-72.7
-5.8

cash-flows.row.sales-maturities-of-investments

022.562.4120.6
3.5
3.3
50.3
25.9
63.5
405.7
89.1
280.1
615.8
818.7
765.4
252.9
185.1
401.8
183.6
410.5
177.8
35.8
97.2
57.3
103.5
36.7

cash-flows.row.other-investing-activites

0.530050
7.2
3.9
2.6
57.4
1.7
-32.3
-42.1
-39.4
43.2
12.6
-6.5
0.6
60.1
-69.2
-14.7
-86.9
-240.4
-37.4
25.3
0
-4.1
-0.7

cash-flows.row.net-cash-used-for-investing-activites

-54.46-20.8-51.636.6
-27.4
45.2
-15.4
67
96.2
236.8
-14.3
57.5
22.7
113.8
-30.6
-2.1
59.8
8.9
11.7
-128.5
-103.9
-43.5
-12.9
-186.5
26.8
30.3

cash-flows.row.debt-repayment

-80.24-45-50-50
0
-0.1
-140.8
-0.7
-23.2
-90.6
-60.6
-12.2
-120.8
-233.3
-264.4
-125.4
-217.5
-249.7
-133.4
-141.3
-163.6
-44.2
-17.3
-0.4
-0.6
0

cash-flows.row.common-stock-issued

-13.41-600
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0600
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

-5.78-1.4-1.7-0.6
0
0
-2.7
-0.1
-1
-4.1
-4.3
-9.3
-2.3
-6.5
-8.1
-5.7
-8.2
-14.1
-14
-49.6
-45.3
-25.3
-16.6
-21.3
-9.5
-9.5

cash-flows.row.other-financing-activites

91335.166.6-92.1
0
-4
140
0.2
0.4
60
61.6
64.8
41.2
173
266.4
172
192.8
107.7
113
94.4
591.4
43.1
52.2
62.4
3.9
7.5

cash-flows.row.net-cash-used-provided-by-financing-activities

876.98-11.314.9-142.7
0
-4
-3.5
-0.6
-23.7
-34.7
-3.3
43.2
-81.9
-66.7
-6.1
41
-33
-156.1
-34.5
-96.5
382.6
-26.4
18.3
40.6
-6.2
-1.9

cash-flows.row.effect-of-forex-changes-on-cash

0.756.7-4.4-19.9
4.5
17.1
-27.9
21.4
13
0.8
-6.1
-0.2
-3.8
-2
-0.1
-3.7
-3.5
-0.5
-0.1
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

704.11-185.6-146-219
43
35.1
-288.2
110.7
98.9
178.1
135.9
166.4
9.3
34.7
4.8
19.8
-5.2
-182.6
-42.2
-171.5
496.5
-19.9
6.4
76.7
-8.5
10.1

cash-flows.row.cash-at-end-of-period

1928.76161.4347493
711.9
668.8
633.7
922
811.2
712.3
534.2
398.3
231.9
222.6
187.8
183
163.3
168.5
351
393.3
564.8
68.3
88.2
88.3
8
16.6

cash-flows.row.cash-at-beginning-of-period

1224.64347493712
668.8
633.7
922
811.2
712.3
534.2
398.3
231.9
222.6
187.8
183
163.3
168.5
351
393.3
564.8
68.3
88.2
81.8
11.6
16.6
6.5

cash-flows.row.operating-cash-flow

-119.16-160.2-104.8-93
66
-23.2
-241.5
22.9
13.4
-24.8
159.6
65.9
72.4
-10.5
41.6
-15.4
-28.5
-34.8
-19.4
53.4
217.8
50
1.1
222.5
-29.1
-18.3

cash-flows.row.capital-expenditure

-55.05-37.7-23.1-17.7
-32.5
-37.5
-93.2
-109.7
-76.5
-44.3
-42.1
-39.4
-6.2
-5.3
-13.2
-27.4
-75.4
-24.1
-29.1
-249.7
-240.4
-37.4
-77
-77.6
-4.1
-0.7

cash-flows.row.free-cash-flow

-174.21-197.9-127.9-110.7
33.5
-60.7
-334.7
-86.7
-63.1
-69.1
117.5
26.4
66.2
-15.7
28.4
-42.7
-103.9
-59
-48.5
-196.3
-22.5
12.6
-75.9
144.9
-33.1
-19

Kasumiaruande rida

China Reform Health Management and Services Group Co., Ltd. tulud muutusid võrreldes eelmise perioodiga 0.061%. 000503.SZ brutokasum on teatatud 81.99. Ettevõtte tegevuskulud on 188.55, mille muutus võrreldes eelmise aastaga on 8.119%. Kulud amortisatsioonikulud on 39.6, mis on -0.237% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud 188.55, mis näitab 8.119% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on 0, mis on 0.000% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on 0, mis tähendab 0.248% kasvu võrreldes eelmise aastaga. Tegevustulu on -82.67, mis näitab -0.248% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on -0.055%. Eelmise aasta puhaskasum oli -79.79.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991

income-statement-row.row.total-revenue

322.28330.1311.1252.5
207.4
129.9
95.5
184
216.8
193.8
195.1
205.9
192.9
162.9
197.8
272.5
286.7
208.3
201.7
256.4
375
390
342.1
339.7
422.9
295.4
221.2
176.4
99.8
132.6
82.7
75
93.3
112.5

income-statement-row.row.cost-of-revenue

246.84248.1246.6218.7
176.9
163.3
155.6
180.8
147.2
110.1
101
87.2
70.2
87.7
90.5
107.5
94.8
64
88.3
157.8
214.1
201.3
133.4
165
270.2
222.2
207.2
190.1
87.5
131.9
77
62
61.6
0

income-statement-row.row.gross-profit

75.438264.533.8
30.5
-33.4
-60.1
3.2
69.6
83.7
94.1
118.7
122.7
75.1
107.3
165
191.9
144.3
113.5
98.6
160.9
188.7
208.7
174.6
152.7
73.2
14
-13.7
12.3
0.7
5.7
13
31.7
112.5

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

22.62---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

64.49---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

4.734.3111.6100
91.8
-57.2
0.1
1.4
5.3
2.5
80.3
3.2
-0.1
3.6
2.5
0.8
1.2
5.1
0.3
1.2
5.7
8.1
14.9
10.1
11.6
15.8
2.2
-31.2
4.8
7.4
2.3
-0.9
0.6
0

income-statement-row.row.operating-expenses

180.27188.6174.4166.6
147.9
-11.9
130.3
190.1
181.3
165.7
141.6
116.7
109.9
122.6
126.8
154.8
157.2
135.4
177.6
187.1
135.7
101.9
114.4
78.9
65.1
32.7
23.8
37
16.8
23.1
13.5
11.4
20.2
0

income-statement-row.row.cost-and-expenses

427.12436.7421385.3
324.8
151.4
285.9
370.8
328.6
275.8
242.6
203.9
180.1
210.4
217.3
262.3
251.9
199.4
265.9
344.9
349.7
303.2
247.8
243.9
335.3
254.9
230.9
227.1
104.3
155
90.5
73.4
81.8
0

income-statement-row.row.interest-income

0.290.61.64.3
8.2
13.9
12
5.6
11.9
11.8
5.3
14.2
0
10.1
10.5
2.8
4.2
4.5
6.6
4.1
3.3
2.3
0.2
0.2
0.4
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

6.225.122.5
0.5
0.4
0
2.7
0.1
0.7
4.1
4.4
-6.7
2.1
6.3
8.1
5.3
8.3
8.9
14.7
14.5
19.2
20.4
26
21.7
21.2
14.3
24.9
3.8
8.3
0
-6.7
2.5
0

income-statement-row.row.selling-and-marketing-expenses

64.49---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

4.734.326.7-44.2
-125.4
-25.2
7.9
195.1
141.1
122.2
81.1
22.6
22.3
67.8
32.9
3
-20.3
2
62.7
113.8
328.4
13.8
2.9
13.7
1.3
39.7
31.2
-109.9
49.4
-2.6
56.5
29.3
-2.1
-90.9

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

4.734.3111.6100
91.8
-57.2
0.1
1.4
5.3
2.5
80.3
3.2
-0.1
3.6
2.5
0.8
1.2
5.1
0.3
1.2
5.7
8.1
14.9
10.1
11.6
15.8
2.2
-31.2
4.8
7.4
2.3
-0.9
0.6
0

income-statement-row.row.total-operating-expenses

4.734.326.7-44.2
-125.4
-25.2
7.9
195.1
141.1
122.2
81.1
22.6
22.3
67.8
32.9
3
-20.3
2
62.7
113.8
328.4
13.8
2.9
13.7
1.3
39.7
31.2
-109.9
49.4
-2.6
56.5
29.3
-2.1
-90.9

income-statement-row.row.interest-expense

6.225.122.5
0.5
0.4
0
2.7
0.1
0.7
4.1
4.4
-6.7
2.1
6.3
8.1
5.3
8.3
8.9
14.7
14.5
19.2
20.4
26
21.7
21.2
14.3
24.9
3.8
8.3
0
-6.7
2.5
0

income-statement-row.row.depreciation-and-amortization

-5.2333.844.220.8
6.6
32.4
32.7
34.2
28.3
23.1
20.2
28.3
27.2
36.1
44.6
47.6
47
39.6
52.8
64.2
63.5
28.7
20
25.5
36
33.2
30.8
79.3
-45.1
4.6
-56.6
-28.6
1.4
0

income-statement-row.row.ebitda-caps

-85.63---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

-80.4-82.7-109.9-132.7
-117.4
41.2
-182.6
6.8
24.9
38.9
-46.6
21.7
36.3
-8.3
10.9
12.4
13.2
5.7
-1.4
27.3
357.3
100.3
101.9
103.6
82.6
68.6
20.8
-130
40.6
-26.9
48.8
30.2
10.1
112.5

income-statement-row.row.income-before-tax

-75.67-78.4-83.2-176.9
-242.8
16
-182.5
8.2
29.3
40.2
33.5
24.6
35.1
20.3
13.4
13.2
14.4
10.8
-1.3
26.9
358.3
104.5
107
111.6
91.6
82.3
22.3
-160.9
45.1
-22.3
49.9
30.1
10
21.6

income-statement-row.row.income-tax-expense

1.171.91.30.2
0.5
0.5
6.2
8.5
16.2
30.6
14.2
12.3
12.7
1.3
2.6
6.9
8.7
8.2
5.2
2.6
8.3
6.9
3.9
11.4
11.1
0
0
-79.4
3.5
0.7
3.7
2.3
0.8
2.3

income-statement-row.row.net-income

-76.31-79.8-84.5-177.1
-243.3
17.4
-187.8
16.7
28
23.1
25
13
24.1
18
12.2
7.9
5.4
3.6
27.2
42.3
358.1
86.8
93.9
92.7
79.4
82.4
22.3
-160.5
41.5
-23.7
46.2
27.8
9.3
19.3
Sarnased aktsiad
Sind võib huvitada ka:
ALHC
Alignment Healthcare, Inc..
6.635 USD
NASDAQ
CLOV
Clover Health Investments, Corp..
0.737 USD
NASDAQ
HUM
Humana Inc..
320.54 USD
NYSE
PFHO
Pacific Health Care Organization, Inc..
0.65 USD
PNK
UNH
UnitedHealth Group Incorporated.
492.45 USD
NYSE
CI
Cigna Corporation.
341.5 USD
NYSE
CVS.DE
CVS Health Corporation.
51.46 EUR
XETRA
CVS
CVS Health Corporation.
55.9 USD
NYSE
ODPV3.SA
Odontoprev S.A..
12.2 BRL
SAO
UNH.DE
UnitedHealth Group Incorporated.
453.85 EUR
XETRA

Korduma kippuv küsimus

Mis on China Reform Health Management and Services Group Co., Ltd. (000503.SZ) koguvara?

China Reform Health Management and Services Group Co., Ltd. (000503.SZ) koguvara on 1951543466.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on 217129997.000.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on 0.234.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on -0.178.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on -0.237.

Mis on ettevõtte kogutulu?

Kogutulu on -0.249.

Mis on China Reform Health Management and Services Group Co., Ltd. (000503.SZ) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on -79791984.630.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 193940276.000.

Mis on tegevuskulude arv?

Tegevuskulud on 188553843.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 830278613.000.